Abstract
Description: Update of 2003 U.S. Preventive Services Task Force (USPSTF) recommendation about screening for gestational diabetes. Methods: The USPSTF weighed the evidence on maternal and neonatal benefits (reduction in preeclampsia, mortality, brachial plexus injury, clavicular fractures, admission to the neonatal intensive care unit for serious illnesses) and harms (physical and psychological harms) of screening for gestational diabetes identified for their 2003 recommendation and the accompanying systematic review of articles published since the 2003 review for screening after 24 weeks' gestation. Additional searches were performed for evidence published from 1966 to 1999 on screening before 24 weeks. Recommendation: Current evidence is insufficient to assess the balance of benefits and harms of screening for gestational diabetes mellitus, either before or after 24 weeks' gestation. (I statement.).
| Original language | English (US) |
|---|---|
| Pages (from-to) | 759-765 |
| Number of pages | 7 |
| Journal | Annals of internal medicine |
| Volume | 148 |
| Issue number | 10 |
| DOIs | |
| State | Published - May 20 2008 |
Fingerprint
ASJC Scopus subject areas
- Internal Medicine
Cite this
Screening for gestational diabetes mellitus : U.S. preventive services task force recommendation statement. / Calonge, Ned; Petitti, Diana B.; DeWitt, Thomas G.; Gordis, Leon; Gregory, Kimberly D.; Harris, Russell; Isham, George; LeFevre, Michael L.; Loveland-Cherry, Carol; Marion, Lucy Nelle; Moyer, Virginia A.; Ockene, Judith K.; Sawaya, George F.; Siu, Albert L.; Teutsch, Steven M.; Yawn, Barbara P.
In: Annals of internal medicine, Vol. 148, No. 10, 20.05.2008, p. 759-765.Research output: Contribution to journal › Review article
}
TY - JOUR
T1 - Screening for gestational diabetes mellitus
T2 - U.S. preventive services task force recommendation statement
AU - Calonge, Ned
AU - Petitti, Diana B.
AU - DeWitt, Thomas G.
AU - Gordis, Leon
AU - Gregory, Kimberly D.
AU - Harris, Russell
AU - Isham, George
AU - LeFevre, Michael L.
AU - Loveland-Cherry, Carol
AU - Marion, Lucy Nelle
AU - Moyer, Virginia A.
AU - Ockene, Judith K.
AU - Sawaya, George F.
AU - Siu, Albert L.
AU - Teutsch, Steven M.
AU - Yawn, Barbara P.
PY - 2008/5/20
Y1 - 2008/5/20
N2 - Description: Update of 2003 U.S. Preventive Services Task Force (USPSTF) recommendation about screening for gestational diabetes. Methods: The USPSTF weighed the evidence on maternal and neonatal benefits (reduction in preeclampsia, mortality, brachial plexus injury, clavicular fractures, admission to the neonatal intensive care unit for serious illnesses) and harms (physical and psychological harms) of screening for gestational diabetes identified for their 2003 recommendation and the accompanying systematic review of articles published since the 2003 review for screening after 24 weeks' gestation. Additional searches were performed for evidence published from 1966 to 1999 on screening before 24 weeks. Recommendation: Current evidence is insufficient to assess the balance of benefits and harms of screening for gestational diabetes mellitus, either before or after 24 weeks' gestation. (I statement.).
AB - Description: Update of 2003 U.S. Preventive Services Task Force (USPSTF) recommendation about screening for gestational diabetes. Methods: The USPSTF weighed the evidence on maternal and neonatal benefits (reduction in preeclampsia, mortality, brachial plexus injury, clavicular fractures, admission to the neonatal intensive care unit for serious illnesses) and harms (physical and psychological harms) of screening for gestational diabetes identified for their 2003 recommendation and the accompanying systematic review of articles published since the 2003 review for screening after 24 weeks' gestation. Additional searches were performed for evidence published from 1966 to 1999 on screening before 24 weeks. Recommendation: Current evidence is insufficient to assess the balance of benefits and harms of screening for gestational diabetes mellitus, either before or after 24 weeks' gestation. (I statement.).
UR - http://www.scopus.com/inward/record.url?scp=44149095548&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=44149095548&partnerID=8YFLogxK
U2 - 10.7326/0003-4819-148-10-200805200-00008
DO - 10.7326/0003-4819-148-10-200805200-00008
M3 - Review article
VL - 148
SP - 759
EP - 765
JO - Annals of Internal Medicine
JF - Annals of Internal Medicine
SN - 0003-4819
IS - 10
ER -